RPRX
RPRX
GB00BMVP7Y09
Royalty Pharma plc
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
32.9B EUR
24.99B EUR
21.28B EUR
16.56B EUR
Enterprise Value
36.11B EUR
33.14B EUR
29.65B EUR
24.9B EUR
Valuation Multiples
Trailing P/E
30.28x
30.67x
25.66x
30.98x
Forward P/E
9.82x
--
--
--
Price to Sales
12.97x
9.86x
8.72x
9.15x
Price to Book
3.71x
3.66x
3.09x
2.56x
EV/Revenue
14.24x
13.07x
12.15x
13.76x
EV/EBITDA
23.18x
20.16x
17.22x
23.42x
Price to FCF (P/FCF)
--
8.4x
8.15x
8.75x
EV/FCF
--
11.13x
11.35x
13.15x
FCF Yield
-3.63%
11.91%
12.27%
11.43%
ende